Centre de Référence Maladies Sensorielles Génétiques, Hôpital Gui de Chauliac, Montpellier, France; Montpellier University, Montpellier, France; Institute for Neurosciences, INSERM, Montpellier, France.
Centre de Référence Maladies Sensorielles Génétiques, Hôpital Gui de Chauliac, Montpellier, France; Institute for Neurosciences, INSERM, Montpellier, France.
Ophthalmology. 2014 Dec;121(12):2406-14. doi: 10.1016/j.ophtha.2014.06.028. Epub 2014 Jul 29.
To assess the frequency of and to characterize the clinical spectrum and optical coherence tomography findings of vitelliform macular dystrophy linked to IMPG1 and IMPG2, 2 new causal genes expressed in the interphotoreceptor matrix.
Retrospective epidemiologic, clinical, electrophysiologic, and molecular genetic study.
The database of a national referral center specialized in genetic sensory diseases was screened for patients with a macular vitelliform dystrophy without identified mutation or small deletion or large rearrangement in BEST1 and PRPH2 genes. Forty-nine families were included.
Clinical, imaging, and electro-oculogram findings were reviewed. Mutation screening of IMPG1 and IMPG2 genes were performed systematically.
Frequency, inheritance, and clinical pattern of vitelliform dystrophy associated with IMPG1 and IMPG2 mutations were characterized.
IMPG1 was the causal gene in 3 families (IMPG1 1-3, 11 patients) and IMPG2 in a fourth family (2 patients). With an autosomal dominant transmission, families 1 and 2 had the c.713T→G (p.Leu238Arg) mutation in IMPG1 and family 4 had the c.3230G→T (p.Cys1077Phe) mutation in IMPG2. Patients with IMPG1 or IMPG2 mutations had a late onset and moderate visual impairment (mean visual acuity, 20/40; mean age of onset, 42 years), even in the sporadic case of family 3 with a presumed recessive transmission (age at onset, 38 years; mean visual acuity, 20/50). Drusen-like lesions adjacent to the vitelliform deposits were observed in 9 of 13 patients. The vitelliform material was above the retinal pigment epithelium (RPE) at any stage of the macular dystrophy, and this epithelium was well preserved and maintained its classical reflectivity on spectral-domain optical coherence tomography (SD-OCT). Electro-oculogram results were normal or borderline in 9 cases.
IMPG1 and IMPG2 are new causal genes in 8% of families negative for BEST1 and PRPH2 mutations. These genes should be screened in adult-onset vitelliform dystrophy with (1) moderate visual impairment, (2) drusen-like lesions, (3) normal reflectivity of the RPE line on SD-OCT, and (4) vitelliform deposits located between ellipsoid and interdigitation lines on SD-OCT. These clinical characteristics are not observed in the classical forms of BEST1 or PRPH2 vitelliform dystrophies.
评估与 IMPG1 和 IMPG2 相关的玻璃体黄斑营养不良的临床谱和光相干断层扫描(OCT)特征,这两种新的基因均在光感受器间基质中表达。
回顾性流行病学、临床、电生理和分子遗传学研究。
筛选数据库,数据库是一个专门研究遗传性感觉疾病的国家转诊中心,包含无明确突变或 BEST1 和 PRPH2 基因中微小缺失或大片段重排的黄斑玻璃体营养不良患者。共纳入 49 个家系。
分析临床、影像学和眼电图检查结果。对 IMPG1 和 IMPG2 基因进行系统突变筛查。
分析与 IMPG1 和 IMPG2 基因突变相关的玻璃体营养不良的发生率、遗传方式和临床表型。
IMPGl 是 3 个家系(IMPGl 1-3,11 例患者)的致病基因,IMPGl2 是第 4 个家系(2 例患者)的致病基因。常染色体显性遗传方式,家系 1 和 2 患者存在 IMPG1 的 c.713T→G(p.Leu238Arg)突变,家系 4 患者存在 IMPG2 的 c.3230G→T(p.Cys1077Phe)突变。IMPGl 或 IMPG2 基因突变患者发病较晚,视力中度受损(平均视力 20/40;平均发病年龄 42 岁),甚至在假定为隐性遗传方式的家系 3 中也如此(发病年龄 38 岁;平均视力 20/50)。13 例患者中有 9 例观察到与玻璃体沉积物相邻的类脂沉积样病变。在黄斑营养不良的任何阶段,玻璃体物质均位于视网膜色素上皮(RPE)上方,该上皮在光谱域 OCT 上保持良好,并保持其典型的反射率。9 例眼电图结果正常或接近正常。
IMPGl 和 IMPG2 是 BEST1 和 PRPH2 基因突变阴性家系中 8%的新的致病基因。对于(1)视力中度受损、(2)类脂沉积样病变、(3)SD-OCT 上 RPE 线的正常反射率和(4)SD-OCT 上位于椭圆体和内插线之间的玻璃体沉积物的成年发病的玻璃体营养不良患者,应筛查 IMPGl 和 IMPG2 基因。这些临床特征在经典形式的 BEST1 或 PRPH2 玻璃体营养不良中观察不到。